160 related articles for article (PubMed ID: 8930147)
1. Mechanical and energetic effects of cromakalim on guinea pig left ventricular papillary muscle.
Joseph T; Coirault C; Ducros L; Lecarpentier Y
J Pharmacol Exp Ther; 1996 Nov; 279(2):464-71. PubMed ID: 8930147
[TBL] [Abstract][Full Text] [Related]
2. [Positive inotropic and lusitropic effect of RP 62719, a new class III antiarrhythmia agent].
Beregi JP; Escande D; Coudray N; Chemla D; Mestre M; Péry N; Lecarpentier Y
Arch Mal Coeur Vaiss; 1994 Feb; 87(2):263-9. PubMed ID: 7802535
[TBL] [Abstract][Full Text] [Related]
3. Positive inotropic effects of RP 62719, a new pure class III antiarrhythmic agent, on guinea pig myocardium.
Beregi JP; Escande D; Coudray N; Mery P; Mestre M; Chemla D; Lecarpentier Y
J Pharmacol Exp Ther; 1992 Dec; 263(3):1369-76. PubMed ID: 1469640
[TBL] [Abstract][Full Text] [Related]
4. Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening.
Grover GJ; D'Alonzo AJ; Hess T; Sleph PG; Darbenzio RB
Cardiovasc Res; 1995 Nov; 30(5):731-8. PubMed ID: 8595620
[TBL] [Abstract][Full Text] [Related]
5. Modulation of ATP-sensitive K+ channel activity and contractile behavior in mammalian ventricle by the potassium channel openers cromakalim and RP49356.
Ripoll C; Lederer WJ; Nichols CG
J Pharmacol Exp Ther; 1990 Nov; 255(2):429-35. PubMed ID: 2243335
[TBL] [Abstract][Full Text] [Related]
6. Inotropic and lusitropic effects of chlorpromazine on rat left ventricular papillary muscle.
Clergue M; Riou B; Lecarpentier Y
J Pharmacol Exp Ther; 1990 Apr; 253(1):296-304. PubMed ID: 2158547
[TBL] [Abstract][Full Text] [Related]
7. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
Nielsen-Kudsk JE
Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective effects of the potassium channel opener cromakalim: stereoselectivity and effects on myocardial adenine nucleotides.
Grover GJ; Newburger J; Sleph PG; Dzwonczyk S; Taylor SC; Ahmed SZ; Atwal KS
J Pharmacol Exp Ther; 1991 Apr; 257(1):156-62. PubMed ID: 2019983
[TBL] [Abstract][Full Text] [Related]
9. External ATP antagonizes the effect of potassium channel openers in guinea-pig ventricular papillary muscle.
Bott A; Eltze M; Illes P
Eur J Pharmacol; 1992 Mar; 213(1):141-4. PubMed ID: 1499650
[TBL] [Abstract][Full Text] [Related]
10. Action potential shortening and negative inotropic effects of a novel potassium channel opener, NIP-121, as compared with cromakalim in guinea pig ventricular myocardium.
Shigenobu K; Kageyama C; Watanabe M
Jpn J Pharmacol; 1991 Sep; 57(1):117-21. PubMed ID: 1800795
[TBL] [Abstract][Full Text] [Related]
11. ATP-sensitive potassium channels and skeletal muscle function in vitro.
Weselcouch EO; Sargent C; Wilde MW; Smith MA
J Pharmacol Exp Ther; 1993 Oct; 267(1):410-6. PubMed ID: 8229769
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
Grover GJ; D'Alonzo AJ; Garlid KD; Bajgar R; Lodge NJ; Sleph PG; Darbenzio RB; Hess TA; Smith MA; Paucek P; Atwal KS
J Pharmacol Exp Ther; 2001 Jun; 297(3):1184-92. PubMed ID: 11356945
[TBL] [Abstract][Full Text] [Related]
13. K+ channel-opening properties of a novel compound, NIP-121, in guinea pig myocardium as compared with those of cromakalim.
Matsuda T; Okazaki K; Kato Y; Tanaka H; Shigenobu K
J Cardiovasc Pharmacol; 1995 Oct; 26(4):608-13. PubMed ID: 8569223
[TBL] [Abstract][Full Text] [Related]
14. [Role of sarcoplasmic reticulum in the regulation of myocardial relaxation].
Péry-Man N; Chemla D; Coirault C; Suard I; Lecarpentier Y
Arch Mal Coeur Vaiss; 1993 Nov; 86(11):1605-12. PubMed ID: 8010860
[TBL] [Abstract][Full Text] [Related]
15. Potassium channel blockade of atrial negative inotropic responses to P1-purinoceptor and muscarinic receptor agonists and to cromakalim.
Urquhart RA; Ford WR; Broadley KJ
J Cardiovasc Pharmacol; 1993 Feb; 21(2):279-88. PubMed ID: 7679163
[TBL] [Abstract][Full Text] [Related]
16. Na+1-activated and ATP-sensitive K+ channels in the heart.
Sanguinetti MC
Prog Clin Biol Res; 1990; 334():85-109. PubMed ID: 2137936
[No Abstract] [Full Text] [Related]
17. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
[TBL] [Abstract][Full Text] [Related]
18. Effects of JTV-506, a new K+ channel activator, on airway smooth muscle contraction and systemic blood pressure.
Ando T; Kume H; Urata Y; Takagi K
Clin Exp Allergy; 1997 Jun; 27(6):705-13. PubMed ID: 9208193
[TBL] [Abstract][Full Text] [Related]
19. Pinacidil-primed ATP-sensitive potassium channels mediate feedback control of mechanical power output in isolated myocardium of rats and guinea pigs.
Schmid D; Staudacher DL; Plass CA; Loew HG; Fritz E; Steurer G; Chiba P; Moeslinger T
Eur J Pharmacol; 2010 Feb; 628(1-3):116-27. PubMed ID: 19925786
[TBL] [Abstract][Full Text] [Related]
20. The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations.
Stehr SN; Christ T; Rasche B; Rasche S; Wettwer E; Deussen A; Ravens U; Koch T; Hübler M
Anesth Analg; 2007 Sep; 105(3):641-7. PubMed ID: 17717217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
